Epidemiology, management, and economic impact of acute myeloid leukemia and myelodysplastic syndrome in Spain at the hospital level: a claims database analysis
Open Access
- 2 November 2020
- journal article
- research article
- Published by Taylor & Francis in Journal of Medical Economics
- Vol. 23 (12) , 1477-1484
Abstract
This study reviewed patient characteristics, management, and medical costs of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDSs) in Spanish hospitals. Data were extracted from the Sp...Keywords
Funding Information
- Jazz Pharmaceuticals
This publication has 17 references indexed in Scilit:
- The outcomes and treatment burden of childhood acute myeloid leukaemia in Australia, 1997–2008: A report from the Australian Paediatric Cancer RegistryPediatric Blood & Cancer, 2015
- Mortality from myelodysplastic syndromes: A multiple causes of death approachAmerican Journal of Hematology, 2014
- The molecular basis of myeloid malignanciesProceedings of the Japan Academy, Series B, 2014
- The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromesLeukemia Research, 2012
- Incidence and prevalence of myelodysplastic syndromes: Data from the Düsseldorf MDS-registryLeukemia Research, 2011
- Molecular Biology of Myelodysplastic SyndromesSeminars in Oncology, 2011
- Estimation of economic costs associated with transfusion dependence in adults with MDSCurrent Medical Research and Opinion, 2009
- Myelodysplastic syndromesCancer, 2007
- Progression of myelodysplasia to acute lymphoblastic leukaemia: Implications for disease biologyLeukemia Research, 2006
- Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate–cytarabine regimenCancer, 2004